重大事件
即時報告
8-K
2026-06-03
Cabaletta Bio提交8-K報告 附臨床試驗及業務進展更新
AI 繁中摘要
Cabaletta Bio, Inc.（CABA）於2026年6月3日向美國證監會提交8-K表格，申報類型為即時報告 📄。本次報告涵蓋三項主要條目：第7.01項（Regulation FD披露）、第8.01項（其他事件）及第9.01項（財務報表及展品）。
公司同步提交了兩份關鍵附件：EX-99.1（新聞稿）及EX-99.2（投資者簡報），並附帶大量圖表圖像，顯示管理層向市場傳達了最新業務進展。雖然具體內容未在摘要中全文列出，但此類8-K通常涉及臨床試驗數據更新、監管里程碑、合作協議或融資活動等重大非公開信息。
Cabaletta Bio為一家專注B細胞相關自身免疫疾病治療的生物製藥公司，其核心候選藥物descartes-08及descartes-15正處於臨床開發階段。本次文件未披露具體財務數字，投資者應仔細查閱附件原文，以了解管理層對未來發展的展望及對公司價值的潛在影響 ⚠️。如涉及監管FD披露，相關信息可能對股價產生短期波動，建議密切留意後續公告。
展開英文正文
EDGAR Filing Documents for 0001759138-26-000030 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001759138-26-000030 Filing Date 2026-06-03 Accepted 2026-06-03 07:02:06 Documents 63 Period of Report 2026-06-03 Items Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K caba-20260603.htm iXBRL 8-K 77831 2 EX-99.1 caba-ex99_1.htm EX-99.1 46471 3 EX-99.2 caba-ex99_2.htm EX-99.2 83952 4 GRAPHIC img132663336_0.jpg GRAPHIC 35776 5 GRAPHIC caba-ex99_2s1.jpg GRAPHIC 195902 6 GRAPHIC caba-ex99_2s2.jpg GRAPHIC 1112990 7 GRAPHIC caba-ex99_2s3.jpg GRAPHIC 181669 8 GRAPHIC caba-ex99_2s4.jpg GRAPHIC 662186 9 GRAPHIC caba-ex99_2s5.jpg GRAPHIC 390452 10 GRAPHIC caba-ex99_2s6.jpg GRAPHIC 480050 11 GRAPHIC caba-ex99_2s7.jpg GRAPHIC 411370 12 GRAPHIC caba-ex99_2s8.jpg GRAPHIC 152090 13 GRAPHIC caba-ex99_2s9.jpg GRAPHIC 451787 14 GRAPHIC caba-ex99_2s10.jpg GRAPHIC 362828 15 GRAPHIC caba-ex99_2s11.jpg GRAPHIC 547141 16 GRAPHIC caba-ex99_2s12.jpg GRAPHIC 492841 17 GRAPHIC caba-ex99_2s13.jpg GRAPHIC 159306 18 GRAPHIC caba-ex99_2s14.jpg GRAPHIC 505081 19 GRAPHIC caba-ex99_2s15.jpg GRAPHIC 384047 20 GRAPHIC caba-ex99_2s16.jpg GRAPHIC 454105 21 GRAPHIC caba-ex99_2s17.jpg GRAPHIC 502017 22 GRAPHIC caba-ex99_2s18.jpg GRAPHIC 441051 23 GRAPHIC caba-ex99_2s19.jpg GRAPHIC 514220 24 GRAPHIC caba-ex99_2s20.jpg GRAPHIC 347647 25 GRAPHIC caba-ex99_2s21.jpg GRAPHIC 558396 26 GRAPHIC caba-ex99_2s22.jpg GRAPHIC 473008 27 GRAPHIC caba-ex99_2s23.jpg GRAPHIC 149490 28 GRAPHIC caba-ex99_2s24.jpg GRAPHIC 450888 29 GRAPHIC caba-ex99_2s25.jpg GRAPHIC 486389 30 GRAPHIC caba-ex99_2s26.jpg GRAPHIC 397315 31 GRAPHIC caba-ex99_2s27.jpg GRAPHIC 148976 32 GRAPHIC caba-ex99_2s28.jpg GRAPHIC 500078 33 GRAPHIC caba-ex99_2s29.jpg GRAPHIC 426905 34 GRAPHIC caba-ex99_2s30.jpg GRAPHIC 537784 35 GRAPHIC caba-ex99_2s31.jpg GRAPHIC 153661 36 GRAPHIC caba-ex99_2s32.jpg GRAPHIC 414479 37 GRAPHIC caba-ex99_2s33.jpg GRAPHIC 425523 38 GRAPHIC caba-ex99_2s34.jpg GRAPHIC 499778 39 GRAPHIC caba-ex99_2s35.jpg GRAPHIC 406848 40 GRAPHIC caba-ex99_2s36.jpg GRAPHIC 140978 41 GRAPHIC caba-ex99_2s37.jpg GRAPHIC 526330 42 GRAPHIC caba-ex99_2s38.jpg GRAPHIC 366577 43 GRAPHIC caba-ex99_2s39.jpg GRAPHIC 419780 44 GRAPHIC caba-ex99_2s40.jpg GRAPHIC 149332 45 GRAPHIC caba-ex99_2s41.jpg GRAPHIC 454945 46 GRAPHIC caba-ex99_2s42.jpg GRAPHIC 386606 47 GRAPHIC caba-ex99_2s43.jpg GRAPHIC 406483 48 GRAPHIC caba-ex99_2s44.jpg GRAPHIC 475117 49 GRAPHIC caba-ex99_2s45.jpg GRAPHIC 467664 50 GRAPHIC caba-ex99_2s46.jpg GRAPHIC 130403 51 GRAPHIC caba-ex99_2s47.jpg GRAPHIC 423978 52 GRAPHIC caba-ex99_2s48.jpg GRAPHIC 390610 53 GRAPHIC caba-ex99_2s49.jpg GRAPHIC 123542 54 GRAPHIC caba-ex99_2s50.jpg GRAPHIC 366453 55 GRAPHIC caba-ex99_2s51.jpg GRAPHIC 192469 Complete submission text file 0001759138-26-000030.txt 28231115 Data Files Seq Description Document Type Size 56 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20260603.xsd EX-101.SCH 26027 66 EXTRACTED XBRL INSTANCE DOCUMENT caba-20260603_htm.xml XML 4937 Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100 Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings) EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 261058900 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)